EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Maternal Plasma miRNAs as Early Biomarkers of Moderate-to-Late-Preterm Birth

Farha Ramzan iD, Jing Rong, Claire T Roberts iD, Justin M O'Sullivan iD, Jo K Perry iD, Rennae Taylor iD, Lesley McCowan, Mark H Vickers iD

International Journal of Molecular Sciences · 02.09.2024 · 25 (17) · 9536

DOI: 10.3390/ijms25179536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.09.2024. Verfasst von Farha Ramzan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liggins Institute, University of Auckland, Auckland 1142, New Zealand. Hauptthemen laut MEDLINE: Premature Birth, MicroRNAs, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, Auckland Medical Research Foundation, Royal Society Te Apārangi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, preterm birth (PTB) is a primary cause of mortality and morbidity in infants, with PTB rates increasing worldwide over the last two decades. Biomarkers for accurate early prediction of PTB before the clinical event do not currently exist. Given their roles in the development and progression of many disease states, there has been increasing interest in the utility of microRNAs (miRNAs) as early biomarkers for pregnancy-related disorders, including PTB. The present study was designed to examine potential differences in miRNA abundances in maternal plasma from mothers with infants born following a moderate to late (28–36 weeks’ gestation, n = 54) spontaneous PTB (SPTB) compared to mothers with matched term infants (n = 54). Maternal plasma collected at 15 weeks’ gestation were utilised from the Auckland and Adelaide cohorts from the Screening for Pregnancy Endpoints (SCOPE) study. miRNAs in plasma were quantified using the NanoString nCounter expression panel (800 miRNAs). The top four most abundant miRNAs were significantly decreased in the plasma of mothers in the SPTB group with results consistent across both cohorts and pathway analysis was undertaken to examine the biological processes linked to the dysregulated miRNAs. The top candidate miRNAs (miRs-451a, −223-3p, let-7a-5p, and -126-3p) were linked to gene pathways associated with inflammation, apoptosis, and mitochondrial biogenesis. Moreover, miRNAs were consistently less abundant in the plasma of mothers of preterm infants across both sites, suggesting potential global dysregulation in miRNA biogenesis. This was supported by a significant downregulation in expression of key genes that are involved in miRNA biogenesis (DROSHA, DICER, and AGO2) across both sites in the SPTB group. In summary, the present study has identified miRNAs in maternal plasma that may provide predictive utility as early biomarkers for the risk of later SPTB. Importantly, these observations were conserved across two independent cohorts. Further, our data provide evidence for a persistent decrease in miRNA abundance in mothers who later experienced an SPTB, which is likely to have widespread consequences for gene regulation and epigenetic processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthMicroRNAsBiomarkersHumansFemalePregnancyAdultInfant, NewbornGestational Age

Stichwörter der Autor:innen

biomarkerepigeneticsmiRNApregnancypreterm birth

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Liggins Institute, University of Auckland, Auckland 1142, New Zealand.
  • Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide 5001, Australia.
  • Maurice Wilkins Centre, University of Auckland, Auckland 1142, New Zealand.
  • Department of Obstetrics and Gynaecology, Faculty of Medical and Health Science, University of Auckland, Auckland 1142, New Zealand.

ORCID-Profile: Farha Ramzan, Claire T Roberts, Justin M O'Sullivan, Jo K Perry, Rennae Taylor, Mark H Vickers

Förderung

  • Health Research Council of New Zealand
  • Auckland Medical Research Foundation
  • Royal Society Te Apārangi
  • National Health and Medical Research Council of Australia
  • Royal Society of New Zealand
  • National Health and Medical Research Council of Australia (NHMRC) Investigator Grant
  • a Matthew Flinders Fellowship from Flinders University

Zitieren

APA

Ramzan, F., Rong, J., Roberts, C. T., O'Sullivan, J. M., Perry, J. K., Taylor, R., McCowan, L., & Vickers, M. H. (2024). Maternal Plasma miRNAs as Early Biomarkers of Moderate-to-Late-Preterm Birth. International Journal of Molecular Sciences, 25(17), 9536. https://doi.org/10.3390/ijms25179536

Vancouver

Ramzan F, Rong J, Roberts CT, O'Sullivan JM, Perry JK, Taylor R, et al. Maternal Plasma miRNAs as Early Biomarkers of Moderate-to-Late-Preterm Birth. International Journal of Molecular Sciences. 2024;25(17):9536. doi:10.3390/ijms25179536

BibTeX
@article{Ramzan2024,
  author = {Ramzan, Farha and Rong, Jing and Roberts, Claire T and O'Sullivan, Justin M and Perry, Jo K and Taylor, Rennae and McCowan, Lesley and Vickers, Mark H},
  title = {Maternal Plasma miRNAs as Early Biomarkers of Moderate-to-Late-Preterm Birth},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {17},
  pages = {9536},
  doi = {10.3390/ijms25179536}
}
Kostenlos starten →